Axel Heidenreich

About

Axel Heidenreich is a prominent urological oncologist whose research has profoundly shaped the surgical management of prostate cancer, testicular cancer, and upper tract urothelial carcinoma. He is best known for his rigorous systematic reviews and clinical trials examining the role of robot-assisted radical prostatectomy (RARP) and pelvic lymph node dissection in prostate cancer treatment, with his 2013 work on RARP and lymphadenectomy accumulating over 247 and 155 citations respectively, establishing him as a leading authority on minimally invasive surgical approaches to high-risk disease. Heidenreich has also pioneered the COTRIMS trial — the Cologne Trial of Retroperitoneal Lymphadenectomy in Metastatic Seminoma — offering a compelling surgical alternative to chemotherapy and radiotherapy in clinical stage IIA/B seminoma, a landmark contribution to testicular cancer management. His work extends to salvage prostatectomy following radiation failure, outcomes in advanced PSA disease, and real-world chemotherapy data with cabazitaxel in metastatic castration-resistant prostate cancer. With a body of work spanning surgical technique, oncological outcomes, and prospective clinical research, Heidenreich represents a vital bridge between operative innovation and evidence-based urological oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Pelvic Lymph Node Dissection During Robot-assisted Radical Prostatectomy: Efficacy, Limitations, and Complications—A Systematic Review of the Literature

   247 citations · 2013
2. 2
   The Role of Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection in the Management of High-risk Prostate Cancer: A Systematic Review

   155 citations · 2013
3. 3
   Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS)

   57 citations · 2023
4. 4
   Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis

   30 citations · 2023
5. 5
   Robot-Assisted Radical Prostatectomy for the Treatment of Radiation-Resistant Prostate Cancer: Surgical, Oncological and Short-Term Functional Outcomes

   26 citations · 2013
6. 6
   Real-world experience with cabazitaxel in patients with metastatic castration-resistant prostate cancer: a final, pooled analysis of the compassionate use programme and early access programme

   25 citations · 2019
7. 7
   Nerve sparing retroperitoneal lymph node dissection in clinical stage IIA/B seminoma: The COTRIMS trial.

   15 citations · 2022
8. 8
   Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.

   10 citations · 2012
9. 9
   Chirurgische Therapie des urogenitalen Deszensus

   9 citations · 2018
10. 10
    Interim analysis of the prospective COTRIMS (Cologne Trial of Retroperitoneal Lymphadectomy in Metastatic Seminoma) trial.

    8 citations · 2023

Key Collaborators

Contact & Links